DPHARMA

Quarterly rpt on consolidated results for the financial period ended 31/12/2006

CCM DUOPHARMA BIOTECH BERHAD

Financial Year End

31/12/2006
Quarter4
Quarterly report for the financial period ended31/12/2006
The figureshave not been audited

Attachments

CCMDBIO-Q4 2006.xls
105 KB

SUMMARY OF KEY FINANCIAL INFORMATION
31/12/2006

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/12/2006
31/12/2005
31/12/2006
31/12/2005
RM'000
RM'000
RM'000
RM'000
1Revenue
23,975
22,895
105,100
94,298
2Profit/(loss) before tax
7,491
8,417
38,094
33,459
3Profit/(loss) for the period
6,240
5,981
28,979
23,513
4Profit/(loss) attributable to ordinary equity holders of the parent
6,240
5,981
28,979
23,513
5Basic earnings/(loss) per share (sen)
4.50
4.29
20.89
17.54
6Proposed/Declared dividend per share (sen)
14.50
17.50
21.50
17.50
 
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)
1.0400
1.0100

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my



Announcement Info

Company NameCCM DUOPHARMA BIOTECH BERHAD  
Stock Name CCMDBIO    
Date Announced22 Feb 2007  
CategoryFinancial Results
Reference NoCS-070221-60413